Clinical Trials Sponsored by Wellspect HealthCare

Total 4416 results

ViiV Healthcare
GlaxoSmithKline

Withdrawn

A Drug Interaction Study Evaluating Plasma GSK2248761 and GSK1349572 Pharmacokinetics in Healthy Adult Subjects.

Infection, Human Immunodeficiency Virus I

United States
Pfizer
ViiV Healthcare

Terminated

A Rollover Study For Subjects Discontinuing From UK-453,061 Studies For The Treatment Of HIV-1

HIV-1

United States, United Kingdom, Portugal, Ukraine, Italy, Poland, Switzerland, Argentina, South Africa, Puerto Rico, Brazil, Malaysia
Pfizer
ViiV Healthcare

Terminated

A Long Term Safety Study Of Lersivirine For The Treatment Of HIV-1 Infection In Subjects Who Have Completed Treatment With Lersivirine In Studies A5271015 And A5271022

HIV-1

South Africa, Australia, United Kingdom, Canada, Italy, Poland, Switzerland, Mexico, Brazil
Baxter Healthcare Corporation

Completed

Neck-Worn Monitoring Sensor for - A Study for Monitoring Subjects With Fluid-Management Issues During Dialysis

Heart Failure | Kidney Disease

United States
ViiV Healthcare
GlaxoSmithKline

Withdrawn

A Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C-GSK2248761 Administered as an Oral Suspension to Healthy Adult Subjects

Infection, Human Immunodeficiency Virus

United States
OSF Healthcare System

Unknown

Fecal Microbiota Therapy for Recurrent Clostridium Difficile Colitis

Clostridium Difficile

United States
Baxter Healthcare Corporation

Completed

Fibrin Sealant for the Sealing of Dura Sutures

Dura Defects | Pathological Processes in the Posterior Fossa

United States, Canada
ViiV Healthcare
GlaxoSmithKline

Completed

A Study to Evaluate the Effects of Calcium Carbonate and Ferrous Fumarate on Pharmacokinetics of Dolutegravir in Healthy Adult Subjects

Infection, Human Immunodeficiency Virus
ViiV Healthcare
GlaxoSmithKline

Completed

A Study To Assess GW433908 (Fosamprenavir) Containing Regimens In HIV-1 Infected Subjects

Infection, Human Immunodeficiency Virus

United States, Spain, France, United Kingdom, Chile, Brazil, Italy, Portugal
Baxter Healthcare Corporation

Completed

e-STEPS: Endotoxin-Associated Sterile Peritonitis Observational Study (e-STEPS)

Endotoxin-associated Sterile Peritonitis

United Kingdom, Germany, Hungary, Netherlands, Portugal
ViiV Healthcare
Pfizer

Completed

Non-Interventional Study Of Celsentri® In Treatment Experienced Patients With CCR5-Tropic HIV-Infection

HIV-1
Baxter Healthcare Corporation

Completed

Efficacy and Safety Study of Fibrin Sealant With 4 IU/mL Thrombin, Vapor Heated, Solvent Detergent Treated (FS VH S/D 4) in Face-Lift Procedures

Facial Rhytidectomy (Face-lift)

United States
ViiV Healthcare
Shionogi

Completed

A Study to Evaluate the Pharmacokinetics and Safety of GSK1265744 and Rilpivirine and Dolutegravir and Rilpivirine in Healthy Adult Subjects

Infections, Human Immunodeficiency Virus and Hepatitis

United States
Baxter Healthcare Corporation

Completed

Efficacy and Safety of FS VH S/D 4 S-apr for Flap Adherence in Rhytidectomy

Face-lift | Facial Rhytidectomy

United States
ViiV Healthcare
Pfizer

Completed

A Pilot Study Of A Novel Treatment Regimen, Maraviroc + Ritonavir Boosted Atazanavir, In Treatment Naive HIV-Infected Patients

Human Immunodeficiency Virus-1

United States, Spain, Germany
ViiV Healthcare
GlaxoSmithKline

Completed

HIV-1 Infection Study of Once a Day Versus Twice a Day Protease Inhibitor in Antiretroviral Treatment Naive Adults

HIV-1 Infection | Infection, Human Immunodeficiency Virus I

Germany, Spain, France, Belgium, United Kingdom, Italy, Romania, Russian Federation, Switzerland
ViiV Healthcare
Pfizer

Completed

Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of HIV-1 Infected Subjects (MOTIVATE 2)

HIV Infections

Netherlands, United States, Italy, Spain, United Kingdom, France, Germany, Australia, Switzerland, Belgium, Canada, Poland, Sweden
ViiV Healthcare
Pfizer

Completed

Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of HIV-1 Infected Subjects (MOTIVATE 1)

HIV Infections

United States, Canada
ViiV Healthcare
Pfizer

Completed

Multicenter, Safety Study Of Maraviroc

Acquired Immunodeficiency Syndrome | HIV Infection

Brazil
ViiV Healthcare
GlaxoSmithKline

Completed

HIV Treatment and CVD Events

HIV Infection | Cardiovascular Disease | Acute Myocardial Infarction | Infection, Human Immunodeficiency Virus
ViiV Healthcare
Pfizer

Completed

Pharmacokinetic Interaction Between Maraviroc And Fosamprenavir/Ritonavir In Healthy Subjects

Healthy

Belgium
Baxter Healthcare Corporation

Completed

Safety During Use of Paediatric Triple Chamber Bag Formulas

Infant, Premature, Diseases | Digestive System Disorders | Infant Nutrition Disorders

France, Belgium
Ineos Healthcare Limited

Terminated

Phase III Study to Investigate the Safety and Efficacy of Fermagate and Sevelamer Hydrochloride

Chronic Kidney Failure

United States, Italy, Brazil, Belgium, United Kingdom, Estonia, Bulgaria, Serbia, Israel, Czech Republic, Hungary, Lithuania, Mexico, Slovakia, South Africa
Tyco Healthcare Group

Completed

Pilot Study of the Genius(TM)2 Tympanic Thermometer in Cardiac Patients Requiring Cardiopulmonary Bypass

Cardiac Surgical Procedures

United States
Ineos Healthcare Limited

Completed

Efficacy and Safety Study of Magnesium Iron Hydroxycarbonate for the Reduction of High Blood Phosphate in Hemodialysis Patients

Chronic Kidney Failure

United Kingdom, United States
OSF Healthcare System

Completed

Tolerance of Increased Infusion Rates of Intravenous Fat Emulsions in Very Low Birth Weight Infants

Low Birth Weight
Tyco Healthcare Group

Terminated

Effects of a New Antimicrobial Dressing on Wound Healing and Incidence of Sternal Wound Infections

Surgical Wound Infection

United States
Baxter Healthcare Corporation

Completed

A Subjective Evaluation of Inflow Pain Associated With the Use of an Experimental Solution for Peritoneal Dialysis

End Stage Renal Disease

Sweden
ViiV Healthcare
GlaxoSmithKline

Not yet recruiting

First Time in Human Study of Long Acting VH4524184 Formulations

HIV Infections

United States
ViiV Healthcare
GlaxoSmithKline

Recruiting

VH4524184 Proof-of-Concept in Treatment-Naïve Adults Living With HIV-1

HIV Infections

United States, Spain, Canada, Italy, Argentina, Mexico
Vinmec Healthcare System

Recruiting

Benefit of Acupuncture Combined to Regional Analgesia for Post Operative Pain Relief After Hysterectomy (RAACU)

Pain, Postoperative

Vietnam
Baxter Healthcare Corporation

Not yet recruiting

ModPG3 Neo-Infant ISO 81060

Blood Pressure
Incannex Healthcare Ltd

Recruiting

Safety and Effect on Pain and Function According to RAPID-3 of IHL-675A in Patients With Rheumatoid Arthritis (CHAPPII)

Rheumatoid Arthritis

Australia
Ziv HealthCare Ltd.

Recruiting

BEAT AF - Braking Ectopic Atrial Trends In Atrial Fibrillation

Paroxysmal Atrial Fibrillation

Israel
Baxter Healthcare Corporation

Recruiting

PMCF Study for ADEPT® in LaparoscopicGynecologic Surgery

Adhesion

United States, Germany
Askel Healthcare Ltd

Recruiting

COPLA® Cartilage Implant Pilot Clinical Trial

Cartilage or Osteochondral Defects in the Knee

Estonia, Finland, Sweden
Baxter Healthcare Corporation

Recruiting

BAX602 in Preventing the Adhesion Around Great Cardiac Vessels in Pediatric Patients With Congenital Heart Disease Undergoing Re-do Open Heart Surgery (Japan Trial)

Congenital Heart Disease in Children

Japan
Baxter Healthcare Corporation

Not yet recruiting

Doxil/Caelyx BE Study

Multiple Myeloma | Ovarian Cancer | Metastatic Breast Cancer | AIDS-related Kaposi Sarcoma
Uriach Consumer Healthcare

Recruiting

Efficacy and Speed of Action of a Product to Control Gastric Hydration and Gastroesophageal Reflux (AQUAA)

Oesophageal Reflux | Gastric Reflux | Hyperactivity; Stomach

Spain
AgNovos Healthcare, LLC

Recruiting

STAND - Study of the AGN1 LOEP SV Kit Compared to PMMA in Patients With Vertebral Compression Fractures

Vertebral Compression Fracture | Vertebral Compression | Compression Fracture

United States
QuantumLeap Healthcare Collaborative

Recruiting

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer (I-SPY)

Breast Cancer | Breast Neoplasms | Breast Tumors | HER2-positive Breast Cancer | Angiosarcoma | Locally Advanced Breast Cancer | HER2-negative Breast Cancer | TNBC - Triple-Negative Breast Cancer | Hormone Receptor Positive Tumor | Hormone Receptor Negative Tumor | Early-stage Breast Cancer

United States
Qure Healthcare, LLC

Completed

Establishing Clinical Utility Evidence for Chronic Disease Management Testing Patient Study

Cardiometabolic Syndrome

United States
ViiV Healthcare
GlaxoSmithKline

Completed

A Study to Determine Safety and Efficacy of Dolutegravir/Abacavir/Lamivudine (DTG/ABC/3TC) in Human Immunodeficiency Virus (HIV)-1 Infected Antiretroviral Therapy (ART) Naïve Women (ARIA)

HIV Infections | Infection, Human Immunodeficiency Virus

United States, France, Spain, United Kingdom, Canada, Thailand, Italy, Portugal, Russian Federation, Mexico, Argentina, South Africa, Puerto Rico
Baxter Healthcare Corporation

Completed

Pediatric Study to Evaluate Risk of Developing Essential Fatty Acid Deficiency When Receiving Clinolipid or Standard-of-Care Lipid Emulsion (Part A)

Essential Fatty Acid Deficiency (EFAD)

United States
Legacy Healthcare SA

Completed

Efficacy and Safety of LH-8 in Paediatric Alopecia Areata (AA)

Alopecia Areata | Pediatric Disorder

France, Germany, Bulgaria
ViiV Healthcare
GlaxoSmithKline

Completed

An Efficacy, Safety, and Tolerability Study Comparing Dolutegravir (DTG) Plus Lamivudine (3TC) With Dolutegravir Plus Tenofovir/Emtricitabine in Treatment naïve HIV Infected Participants (Gemini 2)

HIV Infections | Infection, Human Immunodeficiency Virus

United States, Argentina, Spain, Germany, Belgium, Australia, Canada, United Kingdom, Italy, Romania, Taiwan, Russian Federation, Mexico, France, Switzerland, Peru, Poland, Portugal
Qure Healthcare, LLC

Withdrawn

Clinical Utility Study for Exo-PDAC

Pancreas Cancer

United States
OSF Healthcare System

Completed

Interprofessional Group Intervention to Enhance Compassion Satisfaction and Resilience (CSRS)

Compassion Fatigue | Resilience

United States
GE Healthcare
PPD

Completed

A Study to Evaluate the Diagnostic Efficacy of DaTSCAN™ Ioflupane (123I) Injection in Single Photon Emission Computed Tomography (SPECT) for the Diagnosis of Parkinsonian Syndrome (PS) in Chinese Patients

Essential Tremor | Multiple System Atrophy (MSA) | Parkinsonian Syndrome | Parkinson Disease(PD) | Progressive Supranuclear Palsy (PSP)

China
OSF Healthcare System

Enrolling by invitation

Analysis of the Virtual Acute Care at Home Experience (HaH)

Heart Failure | Infections | Hypertension | Diabetes | Fever | Bronchitis | Asthma, Chronic Obstructive Pulmonary Disease (COPD) | Conditions | Renal and Urinary Disorders

United States

Clinical Trials Sponsored by Wellspect HealthCare

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Burundi

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations